Patents by Inventor Giulio Tarro

Giulio Tarro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition containing interferon for the treatment of hpv infections
    Publication number: 20070098687
    Abstract: Disclosed is a liquid pharmaceutical composition containing interferon for peroral administration, and the use thereof in the treatment of infections caused by human papilloma virus (HPV).
    Type: Application
    Filed: April 6, 2004
    Publication date: May 3, 2007
    Inventor: Giulio Tarro
  • Pharmaceutical compositions containing lithium carbonate
    Patent number: 6989159
    Abstract: Once daily pharmaceutical compositions containing lithium carbonate in the form of coated granules.
    Type: Grant
    Filed: August 6, 2001
    Date of Patent: January 24, 2006
    Assignee: JDS Pharmaceuticals, LLC
    Inventor: Giulio Tarro
  • Anti-rhinovirus active agents
    Publication number: 20050222264
    Abstract: Glyoxal derivatives for use in the prevention and treatment of Rhinovirus infections are herein disclosed.
    Type: Application
    Filed: May 5, 2003
    Publication date: October 6, 2005
    Applicant: UNIHART CORPORATION
    Inventor: Giulio Tarro
  • Pharmaceutical compositions containing lithium carbonate
    Publication number: 20050208154
    Abstract: Once daily pharmaceutical compositions containing lithium carbonate in the form of coated granules.
    Type: Application
    Filed: May 5, 2005
    Publication date: September 22, 2005
    Inventor: Giulio Tarro
  • Method of treating viral hepatitis by administration of liquid human ?-interferon
    Patent number: 6884411
    Abstract: Use of natural human ?-interferon for the preparation of a medicament in liquid form to be administered through peroral route at dosages comprised between 100 UI and 500 UI/day, for therapy of viral infections, in particular viral hepatitis, neoplasia and immune diseases in humans and animals.
    Type: Grant
    Filed: February 27, 1997
    Date of Patent: April 26, 2005
    Assignee: Unihart Corporation
    Inventors: Giulio Tarro, Renzo Brozzo
  • Fusion proteins containing tlp peptides
    Publication number: 20050042199
    Abstract: Disclosed are fusion proteins obtained from a combination of TLP peptides and interleukin-2 (IL-2), and their use in cancer immunotherapy.
    Type: Application
    Filed: November 29, 2002
    Publication date: February 24, 2005
    Inventor: Giulio Tarro
  • Compounds with anti-hiv activity
    Publication number: 20040058999
    Abstract: Use of xenaldial, xenalemine and xenalic acid for the treatment of HIV infections and related conditions, particularly AIDS. The invention also relates to pharmaceutical compositions in the form of combined preparations, comprising a compound selected from the group of xenaldial, xenalamine and xenalic acid, and at least an anti-HIV agent selected from the group of protease inhibitors, revers transcriptase inhibitors and integrase inhibitors.
    Type: Application
    Filed: December 20, 2002
    Publication date: March 25, 2004
    Inventor: Giulio Tarro
  • Immunogenic TLP composition
    Publication number: 20040022870
    Abstract: The present invention relates to an immunogenic composition containing at least one protein from TLP or a fragment thereof, and in particular to the compositions wherein these fragments contain at least one of the peptides claimed as SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3 and SEQ ID NO: 4, suitable in therapy against tumoral diseases, and in particular against non-small cell lung carcinoma and urogenital cancer.
    Type: Application
    Filed: July 31, 2003
    Publication date: February 5, 2004
    Inventor: Giulio Tarro
  • Pharmaceutical compositions containing lithium carbonate
    Publication number: 20040013746
    Abstract: “Once-a-Day” pharmaceutical composition containing an amount of lithium carbonate from 300 mg to 900 mg, in the form of coated granules having the following composition: lithium carbonate 93%, ethylcellulose 1.7%, talc 0.8%, polyvinylpyrrolidone 4.5%.
    Type: Application
    Filed: July 28, 2003
    Publication date: January 22, 2004
    Inventor: Giulio Tarro
  • Urogenital carcinoma anti-TLP peptide antibodies, related kits and methods
    Patent number: 6664378
    Abstract: An antibody that binds to a specific urogenital carcinoma tumor liberated protein (TLP) epitope, wherein the TLP comprises GlyProProGluValGlnAsnAlaAsn, is described. Also described are kits comprising the antibody, and methods of identifying TLP, and methods for diagnosing urogenital carcinoma.
    Type: Grant
    Filed: September 14, 2000
    Date of Patent: December 16, 2003
    Assignee: Unihart Corporation
    Inventor: Giulio Tarro
  • Sticking plaster for controlled release of natural interferon
    Publication number: 20030206945
    Abstract: A sticking plaster for controlled release of natural human &agr;-interferon for use in viral therapies, in particular anti-herpes therapies, comprises a thin flexible support and a layered adhesive forming a matrix, a therapeutically effective quantity of the interferon being dispersed in said matrix.
    Type: Application
    Filed: April 18, 2003
    Publication date: November 6, 2003
    Inventors: Giulio Tarro, Renzo Brozzo
  • Urogenital carcinoma tlp complex peptides and antibodies thereof
    Publication number: 20030170750
    Abstract: It is described a peptide comprising a specific urogenital carcinoma TLP epitope, wherein the TLP comprises the aminoacid sequence: GlyProProGluValGlnAsnAlaAsn. Also described are reagents to detect said urogenital TLPs and pharmaceutical compositions.
    Type: Application
    Filed: February 15, 2000
    Publication date: September 11, 2003
    Inventor: Giulio Tarro
  • Tlp peptides and dna sequences coding the same
    Publication number: 20030157116
    Abstract: The present invention generally relates to DNA molecules encoding peptides derived from proteins of the TLP complex. More specifically, the invention is directed to a cDNA sequence coding for a protein of the 100 kDa TLP complex.
    Type: Application
    Filed: December 3, 2002
    Publication date: August 21, 2003
    Inventor: Giulio Tarro
  • IMMUNOGENIC TLP COMPOSITION
    Publication number: 20020031531
    Abstract: The present invention relates to an immunogenic composition comprising at least one protein from TLP or a fragment thereof, and in particular to the compositions wherein said fragments can comprise at least one of the peptides claimed as SEQ ID NO. 1, SEQ ID NO. 2 and SEQ ID NO. 3 in the European Patent No. 9391641.0, or the peptide claimed as SEQ ID NO. I In the Italian Patent Application No. RM96A000496, suitable in therapy against tumoral diseases, and in particular against NSCLC and uro-genital cancer.
    Type: Application
    Filed: June 9, 1999
    Publication date: March 14, 2002
    Inventor: GIULIO TARRO
  • Urogenital carcinoma TLP peptides
    Patent number: 6222010
    Abstract: It is described a peptide consisting of a specific urogential carcinoma TLP epitope, wherein the TLP comprises the amino acid sequence GlyProProGluValGlnAsnAlaAsn. Also described are reagents to detect said urogenital TLP and pharmaceutical compositions.
    Type: Grant
    Filed: April 15, 1999
    Date of Patent: April 24, 2001
    Assignee: Unihart Corporation
    Inventor: Giulio Tarro
  • Antigenic regions of tumor-liberated particles (TLP) complexes and antibodies against the same
    Patent number: 5877294
    Abstract: Peptides comprised within the 100 KDa protein of the TLP complex (i.e., released proteins from tumors) having antigenic activity as well as antibodies thereof, able to react with TLP for diagnostic and clinical purposes.
    Type: Grant
    Filed: June 19, 1996
    Date of Patent: March 2, 1999
    Assignee: Instituto Farmacoterapico Italiano S.p.A.
    Inventor: Giulio Tarro
  • Antigenic regions of tumour-liberated particles (TLP) complexes and antibodies against the same
    Patent number: 5759792
    Abstract: Peptides comprised within the 100 KDa protein of the TLP complex (i.e., released proteins from tumors) having antigenic activity as well as antibodies thereof, able to react with TLP for diagnostic and clinical purposes.
    Type: Grant
    Filed: June 19, 1996
    Date of Patent: June 2, 1998
    Assignee: Instituto Framacoterapico Italiano S.p.A.
    Inventor: Giulio Tarro
  • Antigenic regions of tumor-liberated particles (TLP) complexes and antibodies against the sames
    Patent number: 5747643
    Abstract: Peptides comprised within the 100 KDa protein of the TLP complex (i.e., released proteins from tumors) having antigenic activity as well as antibodies thereof, able to react with TLP for diagnostic and clinical purposes.
    Type: Grant
    Filed: December 22, 1994
    Date of Patent: May 5, 1998
    Assignee: Instituto Farmacoterapico Italiano S.p.A.
    Inventor: Giulio Tarro
  • Preparation of herpes simplex antigen for the diagnosis of carcinoma
    Patent number: 4391911
    Abstract: The invention relates to a process for the industrial production of a product for the diagnosis of carcinoma consisting of an antigen obtained by the infection with Herpes Simplex Virus of cells of guinea-pig kidney, the process comprising three main sections, in the first of which the antigen is produced, in the second section a biochemical purification of the antigen is carried out, while in the third section the product is prepared in preservable condition and confection.
    Type: Grant
    Filed: January 25, 1980
    Date of Patent: July 5, 1983
    Assignee: Depa S.p.A.
    Inventor: Giulio Tarro